Insider Shareholders with Direct Ownership of Atea Pharmaceuticals, Inc. (AVIR)
This section provides a comprehensive overview of the insiders with direct ownership of Atea Pharmaceuticals, Inc. (AVIR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Atea Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Chung K. Chu
> 10% Shareholder |
176,862 | 0 | 1,176,862 $3.86 Million | 1 |
Nov 03, 2020
Added 13.06%
|
| 834,422 | 41,666 | 811,503 $2.66 Million | 4 |
Jun 16, 2024
Added 3.92%
|
|
| 177,371 | 15,843 | 670,208 $2.2 Million | 3 |
Feb 01, 2024
Reduced 2.31%
|
|
|
Jean Pierre Sommadossi
President, CEO, and Chairman |
173,467 | 56,910 | 116,557 $382,306 | 2 |
Feb 01, 2024
Reduced 32.81%
|
| 33,150 | 0 | 83,150 $272,732 | 1 |
Jun 16, 2024
Added 28.5%
|
|
| 33,150 | 17,544 | 65,606 $215,187 | 2 |
Jun 20, 2024
Reduced 21.1%
|
|
| 45,150 | 0 | 56,445 $185,139 | 2 |
Jun 16, 2024
Added 37.0%
|
|
|
Janet Mj Hammond
Chief Development Officer |
46,800 | 14,029 | 35,362 $115,987 | 2 |
Feb 01, 2024
Reduced 28.4%
|
| 33,150 | 0 | 33,150 $108,732 | 1 |
Jun 16, 2024
Added 50.0%
|
|
| 33,150 | 0 | 33,150 $108,732 | 1 |
Jun 16, 2024
Added 50.0%
|
|
|
Maria Arantxa Horga
Chief Medical Officer |
41,534 | 15,870 | 25,664 $84,177 | 2 |
Feb 01, 2024
Reduced 38.21%
|
|
John Vavricka
Chief Commercial Officer |
33,334 | 11,819 | 21,515 $70,569 | 2 |
Feb 01, 2024
Reduced 35.46%
|
|
Wayne Foster
EVP, Chief Accounting Officer |
33,334 | 12,477 | 20,857 $68,410 | 2 |
Feb 01, 2024
Reduced 37.43%
|